Frankfurt
30.05.25 | 08:03
0,001 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | Polarean Imaging PLC - Dr. Bastiaan Driehuys awarded by ATS | - | RNS | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 15.05. | Polarean: Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum | 1 | GlobeNewswire (USA) | ||
| 15.05. | Polarean Imaging's Xenon-MRT gewinnt an Bedeutung in der Lungenmedizin | 2 | Investing.com Deutsch | ||
| 15.05. | Polarean Imaging's Xenon MRI gains traction in pulmonary medicine | 1 | Investing.com | ||
| 15.05. | Polarean Imaging PLC - Xenon MRI featured prominently at ATS 2025 | - | RNS | ||
| 14.05. | AIM Market Roundup: H&T, Polarean Imaging, Corcel | 2 | The Armchair Trader | ||
| 14.05. | Polarean Imaging PLC - Ongoing collaboration with Philips | 2 | RNS | ||
| 08.05. | Polarean Imaging PLC - Final Results | - | RNS | ||
| 25.04. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
| 10.03. | Polarean Imaging PLC - Expansion of Xenon MRI imaging platform | 1 | RNS | ||
| 27.02. | Polarean Imaging PLC - FY24 trading update | - | RNS | ||
| 19.02. | Polarean Imaging PLC - Virtual Investor Day | - | RNS | ||
| 03.02. | Polarean Imaging shares jump as inks first distribution deal in Taiwan | - | Alliance News | ||
| 03.02. | Polarean Imaging PLC - Taiwanese distributor agreement with Sumtage | - | RNS | ||
| 30.01. | Polarean Imaging PLC - Key patent in China secured | - | RNS | ||
| 28.01. | Polarean Imaging PLC - Collaboration to Advance Lung Imaging Innovation | - | RNS | ||
| 28.08.24 | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 359 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 72,80 | +0,89 % | Why Is Medtronic Spinning Off Its Diabetes Business? | ||
| HCA HEALTHCARE | 331,50 | -0,90 % | Kursgewinne für die HCA-Aktie (334,4478 €) | Im Plus liegt aktuell das Wertpapier von HCA . Der jüngste Kurs betrug 379,12 US-Dollar. Ein Kursgewinn in Höhe von 2,53 US-Dollar erfreut derzeit die Aktionäre von HCA. Der Preis für die Aktie liegt... ► Artikel lesen | |
| LANTHEUS | 65,30 | -0,91 % | Lantheus Holdings, Inc.: Lantheus Announces Sale of SPECT Business to SHINE Technologies | Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite®... ► Artikel lesen | |
| AMEDISYS | 81,50 | -1,81 % | Amedisys Q1 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - Amedisys (AMED) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled... ► Artikel lesen | |
| ENVISTA | 16,000 | -1,23 % | Baird Upgrades Envista Holdings (NVST) Stock to Outperform, Raises PT | ||
| CAREDX | 15,620 | +6,88 % | CareDx, Inc.: CareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA bei der Erkennung von Abstoßungsreaktionen bei Organtransplantationspatienten äußerst genau ist | AlloSeq cfDNA entspricht der Leistung des bewährten AlloSure-Tests CareDx bringt mit AlloSeq cfDNA ein innovatives nicht-invasives Transplantationsmonitoring für Patienten auf internationaler... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Third Quarter 2025 Results | Reports 23 Percent Increase in ARR to $20.4 Million and 43 Net New Platform Deployments, Positive Net Income and Record Adjusted EBITDA and Cashflow
HENDERSON... ► Artikel lesen | |
| GT BIOPHARMA | 2,880 | 0,00 % | GT Biopharma, Inc. - 8-K, Current Report | ||
| CARMAT | 0,826 | +0,85 % | CARMAT Completes Enrolment in the EFICAS Clinical Study and Receives Approval From French Authorities for 21 Additional Aeson Implants, While Awaiting Potential Reimbursement of the Device in France | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| CHEMOMETEC | 71,30 | +1,06 % | Chemometec A/S: Continued growth in revenue and operating profit | Trading statement for Q3 2024/25 (1 January - 31 March 2025) Continued growth in revenue and operating profit Revenue was up by 26% in the third quarter of 2024/25 to DKK 124.2 million from DKK 98.9... ► Artikel lesen | |
| HAMILTON THORNE | 1,490 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
| ARRAIL GROUP | 0,270 | 0,00 % | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | ||
| PROMIMIC | 1,620 | +4,18 % | Curiteva & Promimic - Bonded by Innovation | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 9,250 | 0,00 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period January to March 2025 | "A quarter has passed since I took over as acting CEO and it has been an eventful first few months. Despite the turbulent environment, marked by geopolitical uncertainty, we are able to report our second... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 55,71 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
POLAREAN IMAGING PLC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.